ÂÜÀòÂÒÂ×

Douglas V Faller is a prominent medical professional with extensive experience in oncology and cancer research. Currently serving as Chief Medical Officer at Skyhawk Therapeutics since March 2024, Faller also holds roles as Scientific Founder and Chair of the Scientific Advisory Board at Viracta Therapeutics, Inc., and has been a Professor and Director of the Cancer Center at Boston University since 1982. Faller co-founded Phoenicia Biosciences, Inc. in 2010, leading oncology programs and overseeing successful clinical trials. Previous positions include Chief Medical Officer at Oryzon Genomics and Executive Medical Director at Takeda Pharmaceutical Company. Douglas V Faller's academic credentials include an MD from Harvard Medical School and a Ph.D. in Oncology and Cancer Biology from the Massachusetts Institute of Technology.